Thomas Koeglsperger

4.8k total citations · 2 hit papers
30 papers, 3.5k citations indexed

About

Thomas Koeglsperger is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Thomas Koeglsperger has authored 30 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 12 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Thomas Koeglsperger's work include Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (10 papers) and Alzheimer's disease research and treatments (5 papers). Thomas Koeglsperger is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (10 papers) and Alzheimer's disease research and treatments (5 papers). Thomas Koeglsperger collaborates with scholars based in Germany, United States and Austria. Thomas Koeglsperger's co-authors include Howard L. Weiner, Shaomin Li, Dennis J. Selkoe, Ming Jin, Mark P. Jedrychowski, Richard M. Ransohoff, Ron Cialic, Galina Gabriely, Craig S. Moore and Jeffrey D. Rothstein and has published in prestigious journals such as Angewandte Chemie International Edition, Neuron and Journal of Neuroscience.

In The Last Decade

Thomas Koeglsperger

27 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a unique TGF-β–dependent molecular and functional signature in microglia

2013 1.9k citations Thomas Koeglsperger, Howard L. Weiner et al. profile →
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors

2011 534 citations Shaomin Li, Ming Jin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Koeglsperger Germany	15	1.8k	1.0k	981	845	817	30	3.5k
Diego Gómez‐Nicola United Kingdom	30	2.7k 1.5×	1.4k 1.3×	1.2k 1.2×	939 1.1×	602 0.7×	58	4.1k
Arnaud Frouin United States	4	1.9k 1.0×	668 0.6×	1.1k 1.1×	760 0.9×	826 1.0×	4	2.9k
Elizabeth E. Spangenberg United States	9	2.4k 1.3×	1.0k 1.0×	909 0.9×	688 0.8×	578 0.7×	9	3.3k
Hyun B. Choi Canada	33	1.9k 1.0×	583 0.6×	755 0.8×	1.4k 1.7×	1.4k 1.7×	45	4.4k
Mohammed Filali Canada	29	996 0.5×	527 0.5×	1.1k 1.1×	1.2k 1.4×	1.2k 1.5×	47	3.5k
Lasse Dissing‐Olesen Canada	19	2.9k 1.6×	1.3k 1.3×	655 0.7×	1.1k 1.3×	995 1.2×	22	4.2k
Madhuvika Murugan United States	26	1.5k 0.8×	482 0.5×	984 1.0×	580 0.7×	966 1.2×	44	2.9k
Yu Tang China	22	1.4k 0.8×	484 0.5×	738 0.8×	1.3k 1.6×	535 0.7×	47	3.3k
Hendrikus Boddeke Netherlands	40	2.9k 1.6×	1.7k 1.6×	804 0.8×	1.2k 1.5×	1.3k 1.6×	57	5.0k
Yukari Shigemoto‐Mogami Japan	17	1.4k 0.8×	547 0.5×	1.5k 1.5×	803 1.0×	1.2k 1.5×	30	3.7k

Countries citing papers authored by Thomas Koeglsperger

Since Specialization

Citations

This map shows the geographic impact of Thomas Koeglsperger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Koeglsperger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Koeglsperger more than expected).

Fields of papers citing papers by Thomas Koeglsperger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Koeglsperger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Koeglsperger. The network helps show where Thomas Koeglsperger may publish in the future.

Co-authorship network of co-authors of Thomas Koeglsperger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Koeglsperger. A scholar is included among the top collaborators of Thomas Koeglsperger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Koeglsperger. Thomas Koeglsperger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koeglsperger, Thomas, Christian Dresel, Sebastian Haferkamp, et al.. (2025). Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendations. Journal of Neural Transmission. 133(2). 347–359. 2 indexed citations

Nuamah, Joseph, et al.. (2025). EEG-Based Classification of Parkinson’s Disease With Freezing of Gait Using Midfrontal Beta Oscillations. Journal of Integrative Neuroscience. 24(6). 39023–39023.

Reese, René, Thomas Koeglsperger, Christoph Schrader, et al.. (2025). Invasive therapies for Parkinson’s disease: an adapted excerpt from the guidelines of the German Society of Neurology. Journal of Neurology. 272(3). 219–219. 1 indexed citations

Koeglsperger, Thomas, Werner Poewe, Georg Ebersbach, & Günter U. Höglinger. (2025). Dopaminerge Wirkfluktuationen bei der Parkinson-Krankheit. 8(4). 337–347.

Hornung, Simon, Yiyang Wu, Anna Spanopoulou, et al.. (2025). Multi‐Targeting Macrocyclic Peptides as Nanomolar Inhibitors of Self‐ and Cross‐Seeded Amyloid Self‐Assembly of α‐Synuclein. Angewandte Chemie International Edition. 64(14). e202422834–e202422834. 2 indexed citations

Struebing, Felix L., Bernd H. Northoff, Anna Kordelia Kurz, et al.. (2023). Detection of a Parkinson's Disease–Specific MicroRNA Signature in Nasal and Oral Swabs. Movement Disorders. 38(9). 1706–1715. 6 indexed citations

Koeglsperger, Thomas, Felix L. Struebing, Matthias Brendel, et al.. (2023). Neuropathology of incidental Lewy body & prodromal Parkinson’s disease. Molecular Neurodegeneration. 18(1). 32–32. 61 indexed citations

Höllerhage, Matthias, et al.. (2022). Binding Stability of Antibody—α-Synuclein Complexes Predicts the Protective Efficacy of Anti-α-synuclein Antibodies. Molecular Neurobiology. 59(7). 3980–3995. 4 indexed citations

Gao, Pan, Thomas Arzberger, Matthias Höllerhage, et al.. (2021). Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion. Cell Death and Disease. 12(10). 854–854. 64 indexed citations

10.

Palleis, Carla, et al.. (2020). Establishment of a Visual Analog Scale for DBS Programming (VISUAL-STIM Trial). Frontiers in Neurology. 11. 561323–561323.

11.

Kumar, Rohit, Sainitin Donakonda, Stephan A. Müller, et al.. (2020). Basic Fibroblast Growth Factor 2-Induced Proteome Changes Endorse Lewy Body Pathology in Hippocampal Neurons. iScience. 23(8). 101349–101349. 6 indexed citations

12.

Kumar, Rohit, Sainitin Donakonda, Stephan A. Müller, et al.. (2020). FGF2 Affects Parkinson’s Disease-Associated Molecular Networks Through Exosomal Rab8b/Rab31. Frontiers in Genetics. 11. 572058–572058. 14 indexed citations

13.

Koeglsperger, Thomas, Jan H. Mehrkens, & Kai Bötzel. (2020). Bilateral double beta peaks in a PD patient with STN electrodes. Acta Neurochirurgica. 163(1). 205–209. 14 indexed citations

14.

Rösler, Thomas W., Amir Tayaranian Marvian, Matthias Brendel, et al.. (2019). Four-repeat tauopathies. Progress in Neurobiology. 180. 101644–101644. 137 indexed citations

15.

Hell, Franz, Carla Palleis, Jan H. Mehrkens, Thomas Koeglsperger, & Kai Bötzel. (2019). Deep Brain Stimulation Programming 2.0: Future Perspectives for Target Identification and Adaptive Closed Loop Stimulation. Frontiers in Neurology. 10. 314–314. 47 indexed citations

16.

Koeglsperger, Thomas, Carla Palleis, Franz Hell, Jan H. Mehrkens, & Kai Bötzel. (2019). Deep Brain Stimulation Programming for Movement Disorders: Current Concepts and Evidence-Based Strategies. Frontiers in Neurology. 10. 410–410. 137 indexed citations

17.

Sgobio, Carmelo, Thomas Arzberger, Jörg Tost, et al.. (2019). Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson’s disease. Acta Neuropathologica. 139(2). 319–345. 18 indexed citations

18.

Höllerhage, Matthias, Niko-Petteri Nykänen, Thomas W. Rösler, et al.. (2018). Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy. Cell Death and Disease. 9(7). 757–757. 122 indexed citations

19.

Li, Shaomin, Ming Jin, Dainan Zhang, et al.. (2013). Environmental Novelty Activates β2-Adrenergic Signaling to Prevent the Impairment of Hippocampal LTP by Aβ Oligomers. Neuron. 77(5). 929–941. 145 indexed citations

20.

Wu, Henry Yim, Francisco J. Quintana, Andre Pires da Cunha, et al.. (2011). In Vivo Induction of Tr1 Cells via Mucosal Dendritic Cells and AHR Signaling. PLoS ONE. 6(8). e23618–e23618. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact